Fieldfisher has advised biotechnology company, Link Biologics, on their co-equity fundraising for their innovative dry eye disease (DED) program in partnership with Théa Open Innovation, assisted...
Link Biologics’ Fundraising With Théa Open Innovation For Dry Eye Disease Program
Coave Therapeutics’ €21 Million Funding Round
IN BRIEF: Bird & Bird, McDermott Will & Emery, Weil, Gotshal & Manges, advised on the matter. Bird & Bird advised Coave Therapeutics (Horama SAS) with...